NextCure University: Transforming the Delivery of Microlearning Programs to Build an Innovative Workforce Focused on Cross Training

Published on :

NextCure University: Transforming the Delivery of Microlearning Programs to Build an Innovative Workforce Focused on Cross Training By Sarah EllinwoodJune 12, 2023 As you navigate your life science career, it’s [….]

American Gene Technologies Spins Off Addimmune as a Separate Company With a Focus on Curing HIV

Published on :

American Gene Technologies Spins Off Addimmune as a Separate Company With a Focus on Curing HIV By Alex KeownJune 9, 2023 Powered by promising Phase I results from its HIV [….]

5 Questions With Layla Ghaffari, Associate Scientist at American Gene Technologies

Published on :

5 Questions With Layla Ghaffari, Associate Scientist at American Gene Technologies June 6, 2023 “5 Questions With…” is a recurring BioBuzz series where we reach out to interesting people to [….]

Kite Pharma Recognized as Life Science Company of the Year at 2023 ICON Awards

Published on :

(SOURCE: Maryland Tech Council) Kite Pharma Recognized as Life Science Company of the Year at the 2023 ICON Awards By Sarah EllinwoodApril 28, 2023 On April 27, leaders from around [….]

How NextCure Leverages the Unique Biology of LAIR to Treat Different Cancers

Published on :

NC410 alleviates immunosuppression, remodels collagen to increase T cell infiltration (SOURCE: NextCure) How NextCure Leverages the Unique Biology of LAIR to Treat Different Cancers By Sarah EllinwoodApril 18, 2023 Every [….]

Here Are Several BioHealth Capital Region Life Science Companies Hiring Right Now: Q2 2023

Published on :

Here Are Several BioHealth Capital Region Life Science Companies Hiring Right Now: Q2 2023 By Alex KeownApril 13, 2023 Companies within the BioHealth Capital Region hub are hiring for multiple [….]

How NextCure is Approaching Women’s Cancers Differently: Perspectives from Three Scientists

Published on :

How NextCure is Approaching Women’s Cancers Differently: Perspectives from Three Scientists By Sarah EllinwoodMarch 30, 2023 Breast cancer. Cervical cancer. Ovarian cancer. Uterine cancer. Like many cancers that are out [….]

In a Recent M&A Desert, Philly Proves to Be an Oasis

Published on :

There have been two big recent mergers-and-acquisitions involving Philadelphia life science companies. Today, Philadelphia’s Adaptimmune announced a merger with TCR2 Therapeutics. And about two weeks ago, the acquisition of Philly’s Tmunity by Gilead’s Kite closed. Let’s take a closer look at these deals and what it means for the growing Philly cell and gene therapy community.